Pulse Biosciences (PLSE) has issued an update.
Pulse Biosciences, Inc. has launched a rights offering, announced through a press release, following the successful registration with the SEC. This event marks an opportunity for investors to engage with the company as it embarks on this new financial venture. The detailed terms of the offering are outlined in a prospectus, promising to provide investors with the necessary information to participate in the offering.
Find detailed analytics on PLSE stock on TipRanks’ Stock Analysis page.
